eli lilly glp-1 drug Novo, weight-loss drugs should be first option obesity treatments, European doctors say Eli Lilly slashes prices of
Description
The Danish drugmaker's CEO Mike Doustdar celebrated the milestone, saying in an interview with CNBC that Novo was able to accelerate prescriptions even as Lilly introduced its own GLP-1 pill in April
doi:10.1016/s0006-2952(98)00094-x 54
May provide additional metabolic benefits, including improved beta-cell function, reduced glucagon secretion, delayed gastric emptying, and increased satiety 22
However, more clinical studies are needed to fully understand the clinical efficacy and prognostic effects of tirzepatide
Neeland IJ, Linge J, Birkenfeld AL
